CTOR vs GLW · $105.2M cap vs P/E 101, rev $15.63B
Citius Oncology, Inc. (CTOR) versus Corning Incorporated (GLW) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Corning Incorporated (GLW) is a electronic components company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported GLW revenue for 2025-12-31 was $15.63B. Net income was $1.60B. Revenue was up 19.1% from 2024-12-31 to 2025-12-31. GLW currently screens at market cap $44.76B and trailing P/E 100.5.
CTOR currently screens at market cap $105.2M. GLW currently screens at market cap $44.76B and trailing P/E 100.5.
Not investment advice. Open the CTOR and GLW stock pages for the full models.
Not investment advice.